Idiopathic pneumonia syndrome: Changing spectrum of lung injury after marrow transplantation

Transplantation

Volumn 63, Issue 8, 1997, Pages 1079-1086

  Kantrow, Stephen P ^a,b   Hackman, Robert C ^a   Boeckh, Michael ^a   Myerson, David ^a   Crawford, Stephen W ^a,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IDIOPATHIC DISEASE; INCIDENCE; LUNG INFECTION; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; RISK FACTOR;

EID: 0030936671     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199704270-00006     Document Type: Article

References (47)

1. Krowka MJ, Rosenow EC, Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest 1985; 87: 237.
2. Meyers JD, Flournoy N, Thomas ED. Nonbacterial pneumonia after allogeneic marrow transplantation: a review often years' experience. Rev Infect Dis 1982; 4: 1119.
3. Wingard JR, Mellits ED, Sostrin MB, et al. Interstitial pneumonia after allogeneic marrow transplantation. Medicine 1988; 67: 175.
4. Weiner RS, Bortin MM, Gale RP, et al. Interstitial pneumonitis after bone marrow transplantation: assessment of risk factors. Ann Intern Med 1986; 104: 168.
5. Clark JG, Hansen JA, Hertz MI, Parkman R, Jensen L, Peavy H. NHLBI workshop summary: idiopathic pneumonia syndrome following bone marrow transplantation. Am Rev Respir Dis 1992; 147: 1601.
6. Crawford SW, Bowden RA, Hackman RC, Cleaves CA, Meyers JD, Clark JG. Rapid detection of cytomegalovirus pulmonary infection by bronchoalveolar lavage and centrifugation culture. Ann Intern Med 1988; 108: 180.
7. Crawford SW, Hackman RC. Clinical course of idiopathic pneumonia after marrow transplantation. Am Rev Respir Dis 1993; 147: 1393.
8. Crawford SW, Hackman RC, Clark JG. Open lung biopsy diagnosis of diffuse pulmonary infiltrates after marrow transplantation. Chest 1988; 94: 949.
9. Thomas ED, Buckner CD, Storb R. Aplastic anemia treated by marrow transplantation. Lancet 1972; 1: 284.
10. Thomas ED, Storb R. Techniques for human marrow grafting. Blood 1970; 36: 507.
11. Thomas ED, Storb R, Clift RA, et al. Bone-marrow transplantation. N Engl J Med 1975; 292: 832.
12. Storb R, Thomas ED. Allogeneic bone-marrow transplantation. Immunol Rev 1983; 71: 77.
13. Sullivan KM, Storb R. Allogeneic marrow transplantation. Cancer Invest 1984; 2: 27.
14. Deeg HJ, Storb R, Thomas ED, et al. Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study on patients undergoing marrow transplantation for nonlymphoblastic leukemia. Blood 1985; 65: 1325.
15. Storb R, Deeg HJ, Thomas ED, et al. Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease. Blood 1985; 66: 698.
16. Irle C, Deeg HJ, Buckner CD, et al. Marrow transplantation for leukemia following fractionated total body irradiation: a comparative trial of methotrexate and cyclosporine. Leuk Res 1985; 9: 1255.
17. Hughes WT, Rivera GK, Schell MJ, Thornton D, Lott L. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1987; 316: 1627.
18. Bowden RA, Sayers M, Flournoy N, et al. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 1986; 314: 1006.
19. Meyers JD, Reed EC, Shepp DH, et al. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med 1988; 318: 70.
20. Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 1993; 118: 173.
21. Goodrich JM, Mori M, Cleaves CA, et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 1991; 325: 1601.
22. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley & Sons, 1980.
23. Valteau D, Hartmann O, Benhamou E, et al. Nonbacterial non-fungal interstitial pneumonitis following autologous bone marrow transplantation in children treated with high-dose chemotherapy without total-body irradiation. Transplantation 1988; 45: 737.
24. Hackman RC. Lower respiratory tract. In: Sale GE, Shulman HM, eds. The pathology of bone marrow transplantation, chap. 9. New York: Masson, 1984: 156.
25. Wingard JR, Sostrin MB, Vriesendorp HM, et al. Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 1988; 46: 61.
26. Crawford SW, Schwartz DA, Petersen FB, Clark JG. Mechanical ventilation after marrow transplantation: risk factors and clinical outcome. Am Rev Respir Dis 1988; 137: 682.
27. Crawford SW, Petersen FB. Long-term survival from respiratory failure after marrow transplantation. Am Rev Respir Dis 1992; 145: 510.
28. Faber-Langendoen K, Caplan AL, McGlave PB. Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use. Bone Marrow Transplant 1993; 12: 501.
29. Emanuel D, Cunningham I, Jules-Elysee K, et al. Cytomegalo-virus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med 1988; 109: 777.
30. Reed EC, Bowden RA, Dandliker PS, Lilleby KE, Meyers JD. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med 1988; 109: 783.
31. Schmidt GM, Kovacs A, Zaia JA, et al. Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients. Transplantation 1988; 46: 905.
32. Hackman RC, Myerson D, Crawford SW. The pathology of idiopathic pneumonia after bone marrow transplantation. J Cell Biochem Suppl 1994; 18B: 60.
33. Pecego R, Hill R, Appelbaum FR, et al. Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 1986; 42: 515.
34. Anderson JE, Litzow MR, Appelbaum FR, et al. Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience. J Clin Oncol 1993; 11: 2342.
35. Demirer T, Weaver CH, Buckner CD, et al. High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy. J Clin Oncol 1995; 13: 596.
36. Weaver CH, Appelbaum FR, Petersen FB, et al. High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy. J Clin Oncol 1993; 11: 1329.
37. Ratanatharathorn V, Uberti J, Karanes C, et al. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood 1994; 84: 1050.
38. Crawford SW, Longton G, Storb R. Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 1993; 12: 225.
39. Boström L, Ringden O, Sundberg B, Linde A, Tollemar J, Nilsson B. Pretransplant herpes virus serology and graft-versus-host disease. Transplantation 1988; 46: 458.
40. Gratama JW, Zwaan FE, Stijnen T, et al. Herpes virus immunity and acute graft-versus-host disease. Lancet 1987; 1: 471.
41. Boström L, Ringden O, Gratama JW, Jacobsen N, Zwaan F, Nilsson B. The impact of pretransplant herpesvirus serology on acute and chronic graft-versus-host disease: Leukaemia Working Party of the European Group for Bone Marrow Transplantation. Transplant Proc 1990; 22: 206.
42. Jacobsen N, Anderson HK, Skinhoj P, et al. Correlation between donor CMV immunity and chronic GVHD after allogeneic bone marrow transplantation. Scand J Haematol 1986; 36: 465.
43. Gratama JW, Fibbe WE, Naipal AMIH, et al. Cytomegalovirus immunity and T lymphocytes in bone marrow donors and acute GVHD. Bone Marrow Transplant 1986; 1: 141.
44. Jones RB, Mattes S, Shpall EJ, et al. Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine. J Natl Cancer Inst 1993; 85: 640.
45. Cone RW, Hackman RC, Huang M-LW, et al. Human herpesvirus-6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 1993; 329: 156.
46. Barbera JA, Hayahsi S, Hegele RG, Hogg JC. Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by insitu hybridization. Am Rev Respir Dis 1992; 145: 940.
47. Bateman ED, Hayashi S, Kuwano K, Wilke TA, Hogg JC. Latent adenoviral infection in follicular bronchiectasis. Am J Respir Crit Care Med 1995; 151: 170.